Iterum Therapeutics (ITRM) Institutional Ownership → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free ITRM Stock Alerts $1.50 +0.01 (+0.67%) (As of 01:13 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Iterum Therapeutics (NASDAQ:ITRM)CurrentInstitutional OwnershipPercentage9.21%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$214KNumber ofInstitutional Sellers(last 12 months)0 Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITRM Institutional Buying and Selling by Quarter Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects Iterum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2023 Apollon Wealth Management LLC200,000$214K0.0%N/A1.542% 11/10/2022 New Leaf Venture Partners L.L.C.97,084$157K0.1%-93.3%0.794% 10/6/2022 Krilogy Financial LLC20,000$32K0.0%-90.0%0.163% 7/14/2022 Krilogy Financial LLC200,000$40K0.0%N/A0.109% 11/16/2021Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029% 11/15/2021 Franklin Resources Inc.384,200$215K0.0%N/A0.210% Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021 Renaissance Technologies LLC644,567$360K0.0%-80.4%0.353% 10/25/2021 Krilogy Financial LLC81,000$45K0.0%+161.3%0.044% 9/17/2021Virtu Financial LLC83,658$193K0.0%-37.2%0.046% 8/17/2021Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429% 8/16/2021Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014% 8/16/2021Cubist Systematic Strategies LLC89,431$207K0.0%N/A0.050% 8/13/2021 Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836% 8/13/2021 Sigma Planning Corp17,153$40K0.0%N/A0.010% 8/13/2021QS Investors LLC384,200$888K0.0%N/A0.214% 8/12/2021 Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020% 8/11/2021Susquehanna Fundamental Investments LLC66,230$153K0.0%N/A0.037% 8/10/2021National Asset Management Inc.32,100$75K0.0%-61.0%0.018% 8/4/2021 Grimes & Company Inc.146,278$338K0.0%+17.4%0.082% 7/15/2021 Focused Wealth Management Inc100,000$231K0.0%+33.3%0.056% 5/21/2021Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/19/2021Virtu Financial LLC133,197$188K0.0%+209.0%0.074% 5/19/2021Squarepoint Ops LLC50,196$71K0.0%N/A0.028% 5/18/2021Millennium Management LLC75,206$106K0.0%N/A0.042% 5/18/2021 Verition Fund Management LLC112,500$159K0.0%N/A0.063% 5/18/2021Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/18/2021Jane Street Group LLC18,041$25K0.0%N/A0.010% 5/17/2021Royal Bank of Canada19,000$27K0.0%N/A0.011% 5/17/2021 Edmond DE Rothschild Holding S.A.100,000$141K0.0%N/A0.056% 5/17/2021 HRT Financial LP399,479$563K0.0%+3,875.3%0.223% 5/13/2021Barclays PLC50,000$71K0.0%N/A0.028% 5/12/2021 Geode Capital Management LLC96,173$135K0.0%+190.4%0.054% 5/12/2021 Grimes & Company Inc.124,637$176K0.0%+73.1%0.070% 5/12/2021 FineMark National Bank & Trust300,000$423K0.0%N/A0.167% 5/12/2021 UBS Group AG52,961$75K0.0%N/A0.030% 5/4/2021Commonwealth Equity Services LLC18,500$26K0.0%N/A0.010% 2/25/2021 Clear Street Markets LLC55,000$54K0.0%N/A0.045% 2/24/2021Virtu Financial LLC43,111$43K0.0%N/A0.036% 2/10/2021 Renaissance Technologies LLC732,900$725K0.0%N/A1.493% 2/9/2021 Pivotal bioVenture Partners Investment Advisor LLC945,085$935K0.3%N/A1.926% This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects2/3/2021 Focused Wealth Management Inc75,000$74K0.0%N/A0.153% 2/2/2021 Grimes & Company Inc.72,000$71K0.0%N/A0.147% 5/12/2020Granahan Investment Management Inc. MA241,121$653K0.0%-1.4%1.672% 5/11/2020 Ensign Peak Advisors Inc189,853$515K0.0%-17.7%1.317% 5/1/2020 UBS Group AG12,492$34K0.0%+542.3%0.089% (Data available from 1/1/2016 forward) ITRM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITRM shares? During the previous two years, the following institutional investors and hedge funds held shares of Iterum Therapeutics shares: Apollon Wealth Management LLC ($214K), and New Leaf Venture Partners L.L.C. ($157K), Krilogy Financial LLC ($32K).Learn more on ITRM's institutional investors. What percentage of Iterum Therapeutics stock is owned by institutional investors? 9.21% of Iterum Therapeutics stock is owned by institutional investors. Learn more on ITRM's institutional investor holdings. Which institutional investors have been buying Iterum Therapeutics stock? The following institutional investors have purchased Iterum Therapeutics stock in the last 24 months: Apollon Wealth Management LLC ($200K), and Krilogy Financial LLC ($200K). How much institutional buying is happening at Iterum Therapeutics? Institutional investors have bought a total of 400,000 shares in the last 24 months. This purchase volume represents approximately $814.60K in transactions. Which Iterum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Iterum Therapeutics stock in the last 24 months: New Leaf Venture Partners L.L.C. ($1.36M), and Krilogy Financial LLC ($180K). How much institutional selling is happening at Iterum Therapeutics? Institutional investors have sold a total of 1,539,219 shares in the last 24 months. This volume of shares sold represents approximately $2.49M in transactions. Related Companies: Forte Biosciences Major Shareholders Oncternal Therapeutics Major Shareholders Biora Therapeutics Major Shareholders Lipocine Major Shareholders Lumos Pharma Major Shareholders Unity Biotechnology Major Shareholders Aprea Therapeutics Major Shareholders Lisata Therapeutics Major Shareholders TherapeuticsMD Major Shareholders Bullfrog AI Major Shareholders This page (NASDAQ:ITRM) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
